Detection of cutaneous prion protein deposits could help diagnose GPI-anchorless prion disease with neuropathy

Eur J Neurol. 2021 Jun;28(6):2133-2137. doi: 10.1111/ene.14720. Epub 2021 Jan 22.

Abstract

Background and purpose: To investigate prion protein (PrP) deposits in cutaneous tissues of patients of glycosylphosphatidylinositol (GPI)-anchorless prion diseases with neuropathy.

Methods: Cutaneous tissue samples from three patients with GPI-anchorless prion diseases were obtained, two cutaneous biopsy samples from the lower leg of Case 1 (Y162X) and Case 3 (D178fs25), and a cutaneous sample taken from the abdomen during an autopsy of Case 2 (D178fs25). We performed immunohistochemistry for PrP to look for abnormal PrP deposits.

Results: PrP deposits were observed in the dermal papilla, the sweat glands, the hair follicles, the arrector pili muscles, and peripheral nerves of all examined cases of GPI-anchorless prion disease with neuropathy. The abnormal PrP accumulation was frequently localized at the basement membrane, and colocalized with laminin.

Conclusion: Immunohistochemical detection of PrP in cutaneous samples could be used to definitively diagnose GPI-anchorless PrP disease with neuropathy.

Keywords: basement membrane; cutaneous biopsy; glycosylphosphatidylinositol anchor; laminin; prion.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Glycosylphosphatidylinositols
  • Humans
  • Mice
  • Mice, Transgenic
  • Prion Diseases* / diagnosis
  • Prion Proteins / analysis*

Substances

  • Glycosylphosphatidylinositols
  • PRNP protein, human
  • Prion Proteins